Back to the directory
Synvivia
Synvivia applies chemical control over cell behavior
- Status
- Active
- Stage
- Early
- Team size
- 4
- Location
- San Francisco, CA, USA; Berkeley
- Category
- Biotech & Drug Discovery
- Sector
- Industrial Bio
About Synvivia
Synvivia applies chemical control over cell behavior. This allows us to optimize biomanufacturing of high-value biopharmaceutical products.
Artificial IntelligenceBiotechDrug discoveryManufacturingSynthetic Biology
Federal research funding
3 NIH awards totalling $2,791,609, FY2016 to FY2026.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Genetically Encoded Biosafety in a Therapeutically Modified Organism for Obesity
Source: NIH RePORTER.
Securities filings
1 Form D filing on record, 2023.
Filed as Synvivia, Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
